I am a Senior Lecturer working with the Pancreatic Research Group, South West Sydney Clinical Campuses/Ingham Institute, Liverpool. My current research focuses on early detection of pancreatic cancer through identification of possible biomarkers. This will be achieved by using in-vitro and in-vivo models of pancreatic cancer as well as 'omic' techniques to identify potential factors in small extracellular vesicles derived from pancreatic cancer and stellate cells. Once identified, the presence of lead candidate biomarkers will be tested in patients with new-onset diabetes/pancreatic cancer-related diabetes, which is now considered to be a group at 'high risk' of developing pancreatic cancer. 

Prior to joining the field of Pancreatic Research, I worked in the field of Neuroscience, where I completed my PhD in the field of Neuropathic pain in 2016 from School of Medical Sciences, UNSW Medicine. During my PhD, I investigated immune-modulatory approaches for the treatment of neuropathic pain in animal models. Then, in my first post-doctoral years, I worked in the Sensori-Motor Physiology and Therapeutics (SMPT) group in the Translational Neuroscience Facility, where I aimed to identify a potential neuroprotective compound to reduce excitotoxicity following traumatic brain injury.